Ukuba unikwe i-Invega (i-paliperidone), inokuba yonyango lwe-bipolar disorder. Ngamanye amaxesha kunikwe imigaqo-ye-ilebula ye-mania ephawulekayo. Nazi ezinye iinkcukacha omele wazi.
Invega for Treatment
- I-Invega (i-paliperidone) iyeza- antipyychotic imithi ephuma kwi-metabolite esebenzayo ye- risperidone .
- Ivunyiwe yi-Food and Drug Administration (i-FDA), iCandelo leCandelo leCandelo loPhando lweeMpilo laseCanada (TPD) kunye ne-Yurophu yokuHlola iMicrotherapy (EMEA) yokunyanga kwe-schizophrenia. Akuzange kuvunywe ukunyangwa kwengxaki yokuguquka kwe-bipolar; nangona kunjalo, ngokuqhelekileyo ibhalwe kwi-ilebula-mania.
- I-Invega i-formulation-release release, ngoko kufuneka uthabathe kanye kuphela ngosuku, ngokuqhelekileyo kusasa. Ingathathwa kunye okanye ngaphandle kokutya kodwa kufuneka igonywe ngokupheleleyo. Musa ukwahlula la mapilisi.
- Iziphumo eziqhelekileyo ezimalunga nokungazinzi kunye neempawu ze- extrapyramidal .
- I-Invega ithatha isilumkiso esifanayo kunye ne-antipsychotics e-atypical ngokubhekiselele kwengozi yokufa kwabagulayo asebekhulile abaneengqondo zengqondo.
- Qiniseka ukuba ugqirha wakho oyaziyo ukuba uthatha i-Invega okanye i-Risperdal (risperidone) ngaphambi kokuba ungeze amayeza kwi-regimen yakho. Ukusetyenziswa kwezi zi yobini izidakamizwa akuzange kufundwe.
- Unokubona oko kukhangeleka njengepilisi engaphendulwanga kwisigxina sakho ngeli xesha uthabatha le nyilisi. Okuqhelekileyo. Ingowona kuphela igobolondo yepilisi, engayifumani ngexesha lokutya ngenxa yokuveliswa kokukhululwa kwandisa.
- Le chiza alizange ihlolwe okanye ivunyiwe ukuba yonyango lwabantwana okanye abatsha abangaphantsi kweminyaka eyi-18.
> Iingcaciso
> EMEA. (2008, Septemba 6). I-EPAR yeeMveliso zoLuntu ezigunyazisiweyo zokuSebenzisa abantu: Invega
> FDA. (2007, Matshi 30). Iphepha leNgcaciso yeMagulane I-Paliperidone (Ithengiswa njenge-Invega).
> Ezempilo Canada. (2008, uEpreli 4). Isishwankathelo seSigqibo (SBD) INVEGA.
> Ortho-McNeil-Janssen Pharmaceuticals, Inc. (2008, Oktobha 16). Invega (Paliperidone)